{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:43:14Z","timestamp":1787024594228,"version":"build-2736575974"},"reference-count":73,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["SAR"],"DOI":"10.2147\/sar.s315720","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T06:40:15Z","timestamp":1644302415000},"page":"13-23","source":"Crossref","is-referenced-by-count":51,"title":["Current Insights on the Impact of Gamma-Hydroxybutyrate (GHB) Abuse"],"prefix":"10.2147","volume":"Volume 13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1947-0267","authenticated-orcid":true,"given":"Emma","family":"Tay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Kwan Winky","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7791-3025","authenticated-orcid":true,"given":"Bridin","family":"Murnion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1080\/15563650.2020.1726378","volume":"58","author":"Darke","year":"2020","journal-title":"Clin Toxicol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"103230","DOI":"10.1016\/j.drugpo.2021.103230","volume":"94","author":"Dijkstra","year":"2021","journal-title":"Int J Drug Policy"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1056\/NEJMra044047","volume":"352","author":"Snead","year":"2005","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/med.21382","volume":"36","author":"Maitre","year":"2016","journal-title":"Med Res Rev"},{"key":"ref5","unstructured":"World Health Organization. Gamma-hydroxybutyric acid (GHB) critical review report ECoDD. WHO Thirty-fifth Meeting; June 4\u20138; 2012."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1016\/j.forsciint.2017.05.012","volume":"277","author":"Elliott","year":"2017","journal-title":"Forensic Sci Int"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1208\/s12248-020-00543-z","volume":"23","author":"Felmlee","year":"2021","journal-title":"AAPS J"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1080\/15563650.2019.1617419","volume":"58","author":"Stefani","year":"2020","journal-title":"Clin Toxicol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"13404","DOI":"10.1073\/pnas.1204376109","volume":"109","author":"Absalom","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1196\/annals.1369.065","volume":"1074","author":"Abanades","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1111\/bcp.12863","volume":"81","author":"Liechti","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/sj.clpt.6100037","volume":"81","author":"Thai","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1213\/00000539-196211000-00011","volume":"41","author":"Blumenfeld","year":"1962","journal-title":"Anesth Analg"},{"key":"ref14","first-page":"1017","volume":"19","author":"Rubin","year":"1947","journal-title":"Yale J Biol Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3109\/15563650.2012.702218","volume":"50","author":"Schep","year":"2012","journal-title":"Clin Toxicol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.forsciint.2018.08.034","volume":"292","author":"Grela","year":"2018","journal-title":"Forensic Sci Int"},{"key":"ref17","unstructured":"European medicines agency. Avaialble from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/xyrem. Accessed September 25, 2021."},{"key":"ref18","unstructured":"United States Food and Drug Administration. Avaiailbe from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/021196s030lbl.pdf. Accessed September 25, 2021."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1517\/14656566.2014.863278","volume":"15","author":"Skala","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"ref20","first-page":"4654","volume":"19","author":"Busard\u00f2","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000333022","volume":"18","author":"de Jong","year":"2012","journal-title":"Eur Addict Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.drugalcdep.2016.11.014","volume":"170","author":"Dijkstra","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s40263-020-00730-8","volume":"34","author":"Beurmanjer","year":"2020","journal-title":"CNS Drugs"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/BF02191883","volume":"244","author":"Gallimberti","year":"1994","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0893-133X(95)00087-T","volume":"14","author":"Rosen","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1471-0528.1968.tb00137.x","volume":"75","author":"Geldenhuys","year":"1968","journal-title":"J Obstet Gynaecol Br Commonw"},{"key":"ref27","unstructured":"World. Health Organization Commission on Narcotic Drugs Fifty-eighth session. Note by the Secretariat on the scope of control of substances: proposed scheduling recommendations initiated by WHO; 2015. Available from: https:\/\/www.unodc.org\/documents\/commissions\/CND\/CND_Sessions\/CND_58\/ECN72015_8_eV1501009.pdf. Accesed December 20, 2021."},{"key":"ref28","unstructured":"World Drug Report. United Nations publication, Sales No. E.21.XI.8; 2021. Available from: https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/wdr2021.html. Accessed December 20, 2021."},{"key":"ref29","unstructured":"Australian Institute of Health and Welfare. National Drug Strategy Household Survey. Statistics series no. 32. PHE 270; 2019. Available from: https:\/\/www.aihw.gov.au\/reports\/illicit-use-of-drugs\/national-drug-strategy-household-survey-2019\/contents\/summary. Accessed December 20, 2021."},{"key":"ref30","unstructured":"Center for behavioural health statistics and quality. Results from the 2019 national survey on drug use and health: detailed tables. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2020 [cited December 20, 2021]. Avaialble from: https:\/\/www.samhsa.gov\/data\/. Accessed January 6, 2021."},{"key":"ref31","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. European drug report 2021: trends and developments. Luxembourg: Publications Office of the European Union; 2021."},{"key":"ref32","unstructured":"WODC Repository. National drug monitor; 2020. Availalbe from: https:\/\/repository.wodc.nl\/handle\/20.500.12832\/3035. Accessed December 20, 2021."},{"key":"ref33","unstructured":"Advisory Council on the Misuse of Drugs. An assessment of the harms of gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL), and closely related compounds. Available from: https:\/\/www.gov.uk\/government\/publications\/assessment-of-the-harms-of-gamma-hydroxybutyric-acid-gamma-butyrolactone-and-closely-related-compounds. Accessed December 20, 2021."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1071\/SH17146","volume":"15","author":"Hammoud","year":"2018","journal-title":"Sex Health"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.drugpo.2018.02.002","volume":"55","author":"Edmundson","year":"2018","journal-title":"Int J Drug Policy"},{"key":"ref36","unstructured":"Peacock AU, Karlsson A, Price O, et al. Australian drug trends 2020: key findings from the Illicit Drug Reporting System (IDRS) interviews. Available from: https:\/\/ndarc.med.unsw.edu.au\/resource\/australian-drug-trends-2020-key-findings-national-illicit-drug-reporting-system-idrs. Accessed December 20, 2021."},{"key":"ref37","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/add.14848","volume":"115","author":"Arunogiri","year":"2020","journal-title":"Addiction"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/dta.254","volume":"3","author":"Andresen","year":"2011","journal-title":"Drug Test Anal"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.toxlet.2019.07.001","volume":"314","author":"Galicia","year":"2019","journal-title":"Toxicol Lett"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1111\/acem.12516","volume":"21","author":"Dietze","year":"2014","journal-title":"Acad Emerg Med"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/MEJ.0000000000000649","volume":"27","author":"van Helmond","year":"2020","journal-title":"Eur J Emerg Med"},{"key":"ref42","unstructured":"Karlsson ASR, Peacock A Use of GHB amongst sentinel samples of people who regularly use illicit drugs in Adelaide, South Australia, 2020. Drug Trends Bulletin Series. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney; 2021. Available from: https:\/\/ndarc.med.unsw.edu.au\/sites\/default\/files\/ndarc\/resources\/South%20Australia%20GHB%20Use%20FINAL.pdf. Accessed December 20, 2021."},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X19666210610094352","author":"Amsterdam","year":"2021","journal-title":"Curr Neuropharmacol"},{"key":"ref44","unstructured":"Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set (TEDS): 2019. Admissions to and discharges from publicly funded substance use treatment. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2021. Available from: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt35314\/2019_TEDS_Proof.pdf. Accessed December 8, 2021."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.31128\/AJGP-05-19-4953","volume":"49","author":"Phan","year":"2020","journal-title":"Aust J Gen Pract"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1017\/ipm.2014.39","volume":"31","author":"Durgahee","year":"2014","journal-title":"Ir J Psychol Med"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.drugalcdep.2012.12.023","volume":"131","author":"Brunt","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"251","DOI":"10.5694\/mja16.00269","volume":"205","author":"Tay","year":"2016","journal-title":"Med J Aust"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/j.1360-0443.2010.03145.x","volume":"106","author":"Bell","year":"2011","journal-title":"Addiction"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.4172\/2329-6488.1000112","volume":"112","author":"McDonough","year":"2013","journal-title":"J Alcohol Drug Depend"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1177\/1039856218822748","volume":"27","author":"Cappetta","year":"2019","journal-title":"Australas Psychiatry"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1067\/mem.2001.112985","volume":"37","author":"Dyer","year":"2001","journal-title":"Ann Emerg Med"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40263-016-0402-z","volume":"31","author":"Kamal","year":"2017","journal-title":"CNS Drugs"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/s13063-016-1593-9","volume":"17","author":"Lingford-Hughes","year":"2016","journal-title":"Trials"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Abdulrahim D, Bowden-Jones O; on behalf of the NEPTUNE Expert Group. Guidance on the management of acute and chronic harms of club drugs and novel psychoactive substances. novel psychoactive treatment UK network (Neptune). London; 2015. Available from: http:\/\/neptune-clinical-guidance.co.uk\/wp-content\/uploads\/2015\/03\/NEPTUNE-Guidance-March-2015.pdf. Accessed December 20, 2021.","DOI":"10.1017\/9781009182126"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1067\/mem.2001.119454","volume":"38","author":"Sivilotti","year":"2001","journal-title":"Ann Emerg Med"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/01.pra.0000452567.84825.07","volume":"20","author":"Ghio","year":"2014","journal-title":"J Psychiatr Pract"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.drugalcdep.2004.01.012","volume":"75","author":"McDonough","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/08897077.2020.1827124","volume":"42","author":"Vos","year":"2021","journal-title":"Subst Abus"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.drugalcdep.2017.02.026","volume":"176","author":"van Noorden","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s40263-018-0516-6","volume":"32","author":"Beurmanjer","year":"2018","journal-title":"CNS Drugs"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1136\/sextrans-2020-054840","volume":"97","author":"Dr\u00fcckler","year":"2021","journal-title":"Sex Transm Infect"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.forsciint.2016.11.039","volume":"270","author":"Hockenhull","year":"2017","journal-title":"Forensic Sci Int"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1108\/DAT-10-2018-0058","volume":"19","author":"Stuart","year":"2019","journal-title":"Drugs Alcohol Today"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1007\/s00213-018-5025-2","volume":"235","author":"Liakoni","year":"2018","journal-title":"Psychopharmacology"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12024-008-9040-1","volume":"4","author":"Jones","year":"2008","journal-title":"Forensic Sci Med Pathol"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"109958","DOI":"10.1016\/j.forsciint.2019.109958","volume":"303","author":"Griffiths","year":"2019","journal-title":"Forensic Sci Int"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/14740338.2020.1709821","volume":"19","author":"Addolorato","year":"2020","journal-title":"Expert Opin Drug Saf"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/15563650.2018.1519194","volume":"57","author":"Busard\u00f2","year":"2019","journal-title":"Clin Toxicol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"10577","DOI":"10.26355\/eurrev_201912_19753","volume":"23","author":"Busard\u00f2","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11030166","volume":"11","author":"Steuer","year":"2021","journal-title":"Metabolites"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1515\/cclm-2017-0397","volume":"56","author":"Busard\u00f2","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"110857","DOI":"10.1016\/j.forsciint.2021.110857","volume":"325","author":"Bertol","year":"2021","journal-title":"Forensic Sci Int"}],"container-title":["Substance Abuse and Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=78110","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=78110","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T02:45:07Z","timestamp":1674701107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/current-insights-on-the-impact-of-gamma-hydroxybutyrate-ghb-abuse-peer-reviewed-fulltext-article-SAR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":73,"URL":"https:\/\/doi.org\/10.2147\/sar.s315720","relation":{},"ISSN":["1179-8467"],"issn-type":[{"value":"1179-8467","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2]]}}}